Literature DB >> 21686663

Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.

B Chabrol1, K Martens, S Meulemans, A Cano, J Jaeken, G Matthijs, J W M Creemers.   

Abstract

Hypotonia-cystinuria syndrome (HCS) and 2p21 deletion syndrome are two recessive contiguous gene deletion syndromes associated with cystinuria type I. In HCS patients, only SLC3A1 and PREPL are disrupted. In the 2p21 deletion syndrome, two additional genes (C2orf34 and PPM1B) are lost. Molecular analysis of the SLC3A1/PREPL locus was performed in the patients using quantitative polymerase chain reaction (PCR) methods. HCS in both siblings was confirmed with the deletion screen of the SLC3A1/PREPL locus. Fine mapping of the breakpoint revealed a deletion of 77.4 kb, including three genes: SLC3A1, PREPL and C2orf34. Features not present in classical HCS were a mild/moderate mental retardation and a respiratory chain complex IV deficiency. We report the first patients with a deletion of SLC3A1, PREPL and C2orf34. They present with a phenotype intermediate between HCS and 2p21 deletion syndrome.

Entities:  

Year:  2009        PMID: 21686663      PMCID: PMC3027732          DOI: 10.1136/bcr.08.2008.0719

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A sporadic case of cystinuria, respiratory chain and growth hormone deficiencies.

Authors:  Marco Zaffanello; Renzo Beghini; Giorgio Zamboni; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2003-05-15       Impact factor: 3.714

3.  Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation.

Authors:  Kristine Freude; Kirsten Hoffmann; Lars-Riff Jensen; Martin B Delatycki; Vincent des Portes; Bettina Moser; Ben Hamel; Hans van Bokhoven; Claude Moraine; Jean-Pierre Fryns; Jamel Chelly; Jozef Gécz; Steffen Lenzner; Vera M Kalscheuer; Hans-Hilger Ropers
Journal:  Am J Hum Genet       Date:  2004-05-25       Impact factor: 11.025

4.  The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity.

Authors:  Z Szeltner; I Alshafee; T Juhász; R Parvari; L Polgár
Journal:  Cell Mol Life Sci       Date:  2005-10       Impact factor: 9.261

5.  Spb1p is a yeast nucleolar protein associated with Nop1p and Nop58p that is able to bind S-adenosyl-L-methionine in vitro.

Authors:  L Pintard; D Kressler; B Lapeyre
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome.

Authors:  T Kleefstra; M Smidt; M J G Banning; A R Oudakker; H Van Esch; A P M de Brouwer; W Nillesen; E A Sistermans; B C J Hamel; D de Bruijn; J-P Fryns; H G Yntema; H G Brunner; B B A de Vries; H van Bokhoven
Journal:  J Med Genet       Date:  2005-04       Impact factor: 6.318

7.  A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease.

Authors:  R Parvari; I Brodyansky; O Elpeleg; S Moses; D Landau; E Hershkovitz
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

8.  New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype.

Authors:  M Font-Llitjós; M Jiménez-Vidal; L Bisceglia; M Di Perna; L de Sanctis; F Rousaud; L Zelante; M Palacín; V Nunes
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

9.  The 2p21 deletion syndrome: characterization of the transcription content.

Authors:  Ruti Parvari; Yael Gonen; Ismael Alshafee; Sophia Buriakovsky; Kfir Regev; Eli Hershkovitz
Journal:  Genomics       Date:  2005-08       Impact factor: 5.736

10.  Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics.

Authors:  Vamsi K Mootha; Pierre Lepage; Kathleen Miller; Jakob Bunkenborg; Michael Reich; Majbrit Hjerrild; Terrye Delmonte; Amelie Villeneuve; Robert Sladek; Fenghao Xu; Grant A Mitchell; Charles Morin; Matthias Mann; Thomas J Hudson; Brian Robinson; John D Rioux; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-14       Impact factor: 11.205

View more
  5 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

2.  Coexistence of Megaconial Congenital Muscular Dystrophy and Cystinuria: Mimicking Hypotonia-Cystinuria Syndrome.

Authors:  Ilknur Surucu Kara; Ummuhan Oncul; Engin Kose; Husnu Mutlu Turan; Ahmet Cevdet Ceylan; Fatma Tuba Eminoglu
Journal:  Mol Syndromol       Date:  2022-02-03

3.  Prolyl Endopeptidase-Like Facilitates the α-Synuclein Aggregation Seeding, and This Effect Is Reverted by Serine Peptidase Inhibitor PMSF.

Authors:  Gabriel S Santos; William Y Oyadomari; Elizangela A Carvalho; Ricardo S Torquato; Vitor Oliveira
Journal:  Biomolecules       Date:  2020-06-25

4.  Hypotonia-cystinuria 2p21 deletion syndrome: Intrafamilial variability of clinical expression.

Authors:  Atif Towheed; Christian L Hietanen; Vasudeva G Kamath; Larry N Singh; Angela Ho; Kristin Engelstad; Kayla Cornett; Jacqueline Montes; Darryl De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2021-10-06       Impact factor: 4.511

5.  Cystinuria: An Overview of Diagnosis and Medical Management.

Authors:  Sanober Sadiq; Onur Cil
Journal:  Turk Arch Pediatr       Date:  2022-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.